KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
+10.25%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$153M
AUM Growth
+$153M
(+4.6%)
Cap. Flow
+$11.5M
Cap. Flow
% of AUM
7.48%
Top 10 Holdings %
Top 10 Hldgs %
82.43%
Holding
41
New
10
Increased
2
Reduced
1
Closed
2
Top Buys
| 1 |
Applied Therapeutics
APLT
|
$3.26M |
| 2 |
Altria Group
MO
|
$1.16M |
| 3 |
Corning
GLW
|
$1.16M |
| 4 |
CVS Health
CVS
|
$1.09M |
| 5 |
Elicio Therapeutics
ELTX
|
$1.08M |
Top Sells
| 1 |
Anavex Life Sciences
AVXL
|
$3.62M |
| 2 |
MTEM
Molecular Templates, Inc.
MTEM
|
$1.07M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$44.4K |
Sector Composition
| 1 | Healthcare | 79.18% |
| 2 | Materials | 5.78% |
| 3 | Financials | 2.61% |
| 4 | Technology | 2.11% |
| 5 | Communication Services | 1.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $58.6M | 38.16% | 856,844 -650 | -0.1% | -$44.4K |
|
|
2
Applied Therapeutics
APLT
$71M
| $19.2M | 12.53% | 1,025,464 +173,913 | +20% | +$3.26M |
|
3
Corbus Pharmaceuticals
CRBP
$115M
| $9.94M | 6.48% | 5,045,870 | – | – |
|
4
Entera Bio
ENTX
$88.1M
| $6.83M | 4.45% | 1,791,363 +50,000 | +3% | +$190K |
|
5
Aldeyra Therapeutics
ALDX
$351M
| $6.77M | 4.41% | 569,405 | – | – |
|
|
EIGR
6
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $6.14M | 4% | 694,232 | – | – |
|
7
Abeona Therapeutics
ABEO
$350M
| $5.38M | 3.5% | 2,859,767 | – | – |
|
8
Blackstone
BX
$134B
| $2.98M | 1.94% | 40,000 | – | – |
|
9
Lumen
LUMN
$5.1B
| $2.94M | 1.91% | 220,000 | – | – |
|
10
Exicure
XCUR
$35.4M
| $2.79M | 1.82% | 1,277,777 | – | – |
|
11
Dow Inc
DOW
$17.5B
| $1.92M | 1.25% | 30,000 | – | – |
|
12
Corteva
CTVA
$50.4B
| $1.4M | 0.91% | 30,000 | – | – |
|
13
Soligenix
SNGX
$10.1M
| $1.21M | 0.79% | 787,830 | – | – |
|
|
14
Altria Group
MO
$113B
| $1.16M | 0.76% | +22,700 | New | +$1.16M |
|
15
DuPont de Nemours
DD
$32.2B
| $1.16M | 0.76% | 15,000 | – | – |
|
|
16
Corning
GLW
$57.4B
| $1.16M | 0.75% | +26,600 | New | +$1.16M |
|
|
17
CVS Health
CVS
$92.8B
| $1.09M | 0.71% | +14,500 | New | +$1.09M |
|
|
18
Elicio Therapeutics
ELTX
$172M
| $1.08M | 0.71% | +60,000 | New | +$1.08M |
|
19
Booz Allen Hamilton
BAH
$13.4B
| $1.05M | 0.68% | +13,000 | New | +$1.05M |
|
|
VMW
20
DELISTED
VMware, Inc
VMW
| $1.05M | 0.68% | +6,950 | New | +$1.05M |
|
21
Arista Networks
ANET
$172B
| $1.04M | 0.68% | +3,450 | New | +$1.04M |
|
22
Visa
V
$683B
| $1.03M | 0.67% | +4,850 | New | +$1.03M |
|
23
Thermo Fisher Scientific
TMO
$186B
| $958K | 0.62% | +2,100 | New | +$958K |
|
24
BioXcel Therapeutics
BTAI
$59M
| $863K | 0.56% | 20,000 | – | – |
|
25
Altimmune
ALT
$338M
| $707K | 0.46% | 50,000 | – | – |
|